Alteration of gut microbiota in patients with advanced hepatocellular carcinoma.

被引：0
|
作者：
Charoenthanadhol, Thanakorn
Wirasorn, Kosin
Sookprasert, Aumkhae
Chindaprasert, Jarin
Sanlung, Thanachai
Watcharenwong, Piyakarn
Putraveephong, Siraphong
Phetcharaburanin, Jutarop
机构：
[1] Khon Kaen Univ, Fac Med, Muang, Thailand
[2] Khon Kaen Univ, Fac Med, Mueang Khon Kaen, Thailand
[3] Khon Kaen Univ, Fac Med, Khon Kaen, Thailand
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2025年 / 43卷 / 4_SUPPL期
关键词：
D O I：
10.1200/JCO.2025.43.4_suppl.641
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：641 / 641
页数：1
相关论文
共 50 条
  • [21] ALTERATION IN GUT MICROBIOTA ASSOCIATED WITH HEPATITIS B AND NON-HEPATITIS VIRUS RELATED HEPATOCELLULAR CARCINOMA
    Liu, Qisha
    Li, Fan
    Zhuang, Yaoyao
    Xu, Jian
    Zhang, Yewei
    Liu, Xingyin
    GASTROENTEROLOGY, 2019, 156 (06) : S1271 - S1271
  • [22] Alteration in gut microbiota associated with hepatitis B and non-hepatitis virus related hepatocellular carcinoma
    Liu, Qisha
    Li, Fan
    Zhuang, Yaoyao
    Xu, Jian
    Wang, Jianwei
    Mao, Xuhua
    Zhang, Yewei
    Liu, Xingyin
    GUT PATHOGENS, 2019, 11 (1)
  • [23] Gut microbiota in hepatocellular carcinoma immunotherapy: immune microenvironment remodeling and gut microbiota modification
    Huang, Mingyao
    Ji, Quansong
    Huang, Huiyan
    Wang, Xiaoqian
    Wang, Lin
    GUT MICROBES, 2025, 17 (01)
  • [24] Supplement use in patients with hepatocellular carcinoma.
    Lee, Valerie
    Goyal, Abhishek
    Hsu, Christine Cho-Shing
    Rodriguez, Rosa D.
    Siegel, Abby B.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [25] IMMUNOLOGIC FUNCTION IN PATIENTS WITH HEPATOCELLULAR CARCINOMA.
    Lin, Jiunn-Chang
    Chien, Pei-Ju
    Liu, Chien-Liang
    Lee, Jee-Jen
    Liu, Tsan-Pai
    Ko, Wen-Ching
    Shih, Chwen-Ming
    LIVER TRANSPLANTATION, 2009, 15 (07) : S146 - S146
  • [26] Effect of pravastatin on survival in patients with advanced hepatocellular carcinoma. A randomized controlled trial
    S Kawata
    E Yamasaki
    T Nagase
    Y Inui
    N Ito
    Y Matsuda
    M Inada
    S Tamura
    S Noda
    Y Imai
    Y Matsuzawa
    British Journal of Cancer, 2001, 84 : 886 - 891
  • [27] Effect of pravastatin on survival in patients with advanced hepatocellular carcinoma. A randomized controlled trial
    Kawata, S
    Yamasaki, E
    Nagase, T
    Inui, Y
    Ito, N
    Matsuda, Y
    Inada, M
    Tamura, S
    Noda, S
    Imai, Y
    Matsuzawa, Y
    BRITISH JOURNAL OF CANCER, 2001, 84 (07) : 886 - 891
  • [28] Outcome of Living Donor Liver Transplantation for Patients with Far Advanced Hepatocellular Carcinoma.
    Suh, Kyung-Suk
    Hong, Geun
    Kim, Hyeyoung
    Park, Min-Su
    Choi, Young-Rok
    Mori, Shozo
    Shin, Woo Young
    Lee, H. W.
    Yi, Nam-Joon
    Lee, Kwang-Woong
    LIVER TRANSPLANTATION, 2012, 18 : S214 - S214
  • [29] Association between gut microbiota and hepatocellular carcinoma in patients with chronic liver disease
    Honda, Takashi
    Ishigami, Masatoshi
    Yamamoto, Kenta
    Ito, Takanori
    Ishizu, Yoji
    Kuzuya, Teiji
    Fujishiro, Mitsuhiro
    JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E512 - E513
  • [30] Hepatocellular carcinoma.
    Lemoine, A
    Azoulay, D
    Jezequel-Cuer, M
    Debuire, B
    PATHOLOGIE BIOLOGIE, 1999, 47 (09): : 903 - 910
12345